SCHEMBL26177216

SCHEMBL26177216

CC1(C)NC(=O)c2ccc(-c3c[nH]c4ncc(C(=O)Nc5cncc(F)c5)cc34)cc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 15/20 0.55
▸ CLK1 P49759 12/20 0.55
▸ DYRK1B Q9Y463 2/20 0.50
▸ DYRK2 Q92630 1/20 0.47
▸ PRKD3 O94806 5/20 0.41
▸ MAP4K4 O95819 5/20 0.41
▸ NTRK1 P04629 5/20 0.41
▸ AXL P30530 5/20 0.41
▸ FLT4 P35916 5/20 0.41
▸ FLT3 P36888 5/20 0.41
▸ CLK2 P49760 5/20 0.41
▸ MAP4K2 Q12851 5/20 0.41
▸ CAMK2B Q13554 5/20 0.41
▸ CAMK2G Q13555 5/20 0.41
▸ CAMK2D Q13557 5/20 0.41
▸ PTK6 Q13882 5/20 0.41
▸ NTRK3 Q16288 5/20 0.41
▸ PKN2 Q16513 5/20 0.41
▸ MINK1 Q8N4C8 5/20 0.41
▸ PRKD2 Q9BZL6 5/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30399459 1.00 DYRK1A (0.55) DYRK1ACLK1DYRK1BDYRK2PRKD3
SCHEMBL26177220 0.88 DYRK1A (0.53) DYRK1ACLK1DYRK1BDYRK2PRKD3
SCHEMBL30400318 0.88 DYRK1A (0.53) DYRK1ACLK1DYRK1BDYRK2PRKD3
SCHEMBL26177218 0.87 DYRK1A (0.52) DYRK1ACLK1DYRK1BDYRK2PRKD3
SCHEMBL30400687 0.87 DYRK1A (0.52) DYRK1ACLK1DYRK1BDYRK2PRKD3
SCHEMBL26176793 0.82 KIT (0.44) DYRK1ACLK1DYRK1BDYRK2AXL
SCHEMBL26177219 0.81 DYRK1A (0.55) DYRK1ACLK1DYRK1BDYRK2PRKD3
SCHEMBL26177215 0.81 DYRK1A (0.57) DYRK1ACLK1DYRK1BDYRK2PRKD3
SCHEMBL30399726 0.80 DYRK1A (0.51) DYRK1ACLK1DYRK1BDYRK2PRKD3
SCHEMBL26175183 0.80 DYRK1A (0.51) DYRK1ACLK1DYRK1BDYRK2PRKD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192686-A1 1H-PYRROLO[2,3-B]PYRIDINES AND PREPARATION AND USES THEREOF TENARX, INC. 2023-06-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192686-A1 1H-PYRROLO[2,3-B]PYRIDINES AND PREPARATION AND USES THEREOF DYRK1A, DYRK1B, DYRK2 DYRK1A 1/4885CLK1 268/4885DYRK1B 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback